Analyst Price Target is $1,144.00
▲ +6,669.23% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Coloplast A/S in the last 3 months. The average price target is $1,144.00, with a high forecast of $1,144.00 and a low forecast of $1,144.00. The average price target represents a 6,669.23% upside from the last price of $16.90.
Current Consensus is
The current consensus among 7 contributing investment analysts is to hold stock in Coloplast A/S. This Hold consensus rating has held steady for over two years.
Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.